Scott Braunstein
2016 - Pacira Pharmaceuticals
In 2016, Scott Braunstein earned a total compensation of $1.6M as Senior Vice President, Strategy and Corporate Development at Pacira Pharmaceuticals, a 42% decrease compared to previous year.
Compensation breakdown
| Bonus | $134,400 |
|---|---|
| Option Awards | $680,476 |
| Salary | $419,039 |
| Stock Awards | $352,975 |
| Other | $966 |
| Total | $1,587,856 |
Braunstein received $680.5K in option awards, accounting for 43% of the total pay in 2016.
Braunstein also received $134.4K in bonus, $419K in salary, $353K in stock awards and $966 in other compensation.
Rankings
In 2016, Scott Braunstein's compensation ranked 5,980th out of 14,075 executives tracked by ExecPay. In other words, Braunstein earned more than 57.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,980 out of 14,075 | 58th |
Division Manufacturing | 2,173 out of 5,486 | 60th |
Major group Chemicals And Allied Products | 713 out of 1,900 | 63rd |
Industry group Drugs | 537 out of 1,543 | 65th |
Industry Pharmaceutical Preparations | 420 out of 1,173 | 64th |
Source: SEC filing on April 21, 2017.
Braunstein's colleagues
We found five more compensation records of executives who worked with Scott Braunstein at Pacira Pharmaceuticals in 2016.
2016
David Stack
Pacira Pharmaceuticals
Chief Executive Officer
2016
Charles Reinhart
Pacira Pharmaceuticals
Chief Financial Officer
2016
James Scibetta
Pacira Pharmaceuticals
Chief Financial Officer
2016
Robert Weiland
Pacira Pharmaceuticals
Chief Commercial Officer
2016
Kristen Williams
Pacira Pharmaceuticals